192 related articles for article (PubMed ID: 22791286)
21. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells.
Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC
Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445
[TBL] [Abstract][Full Text] [Related]
22. TNFα and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis.
Jiang Y; Zhang Q; Soderland C; Steinle JJ
Cell Signal; 2012 May; 24(5):1086-92. PubMed ID: 22266116
[TBL] [Abstract][Full Text] [Related]
23. Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effects.
Son HN; Nam JO; Kim S; Kim IS
Biochim Biophys Acta; 2013 Oct; 1833(10):2378-88. PubMed ID: 23792174
[TBL] [Abstract][Full Text] [Related]
24. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
Ishizuka K; Usui I; Kanatani Y; Bukhari A; He J; Fujisaka S; Yamazaki Y; Suzuki H; Hiratani K; Ishiki M; Iwata M; Urakaze M; Haruta T; Kobayashi M
Endocrinology; 2007 Jun; 148(6):2994-3003. PubMed ID: 17379643
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II induces angiogenic factors production partly via AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells.
Ji Y; Wang Z; Li Z; Li K; Le X; Zhang T
Cell Physiol Biochem; 2012; 29(5-6):863-74. PubMed ID: 22613986
[TBL] [Abstract][Full Text] [Related]
26. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling.
Kimura A; Kinjyo I; Matsumura Y; Mori H; Mashima R; Harada M; Chien KR; Yasukawa H; Yoshimura A
J Biol Chem; 2004 Feb; 279(8):6905-10. PubMed ID: 14699146
[TBL] [Abstract][Full Text] [Related]
27. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
[TBL] [Abstract][Full Text] [Related]
28. SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3 signaling pathway in 3T3-L1 adipocyte.
Liu Z; Gan L; Zhou Z; Jin W; Sun C
Immunobiology; 2015 Aug; 220(8):947-53. PubMed ID: 25720636
[TBL] [Abstract][Full Text] [Related]
29. SOCS3 was induced by hypoxia and suppressed STAT3 phosphorylation in pulmonary arterial smooth muscle cells.
Bai L; Yu Z; Qian G; Qian P; Jiang J; Wang G; Bai C
Respir Physiol Neurobiol; 2006 May; 152(1):83-91. PubMed ID: 16125475
[TBL] [Abstract][Full Text] [Related]
30. Expression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli.
Demirel I; Säve S; Kruse R; Persson K
APMIS; 2013 Feb; 121(2):158-67. PubMed ID: 23030674
[TBL] [Abstract][Full Text] [Related]
31. Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes.
Weskamp G; Mendelson K; Swendeman S; Le Gall S; Ma Y; Lyman S; Hinoki A; Eguchi S; Guaiquil V; Horiuchi K; Blobel CP
Circ Res; 2010 Mar; 106(5):932-40. PubMed ID: 20110534
[TBL] [Abstract][Full Text] [Related]
32. Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction.
Hiwatashi K; Tamiya T; Hasegawa E; Fukaya T; Hashimoto M; Kakoi K; Kashiwagi I; Kimura A; Inoue N; Morita R; Yasukawa H; Yoshimura A
Cancer Lett; 2011 Sep; 308(2):172-80. PubMed ID: 21624767
[TBL] [Abstract][Full Text] [Related]
33. Suppressor of cytokine signaling 3 negative regulation of signal transducer and activator of transcription 3 in platelet-derived growth factor-induced fibroblast migration.
Nagai H; Tokumaru S; Sayama K; Shirakata Y; Hanakawa Y; Hirakawa S; Dai X; Tohyama M; Yang L; Hashimoto K
J Dermatol; 2007 Aug; 34(8):523-30. PubMed ID: 17683382
[TBL] [Abstract][Full Text] [Related]
34. SOCS3 regulates pathological retinal angiogenesis through modulating SPP1 expression in microglia and macrophages.
Wang T; Kaneko S; Kriukov E; Alvarez D; Lam E; Wang Y; La Manna S; Marasco D; Fernandez-Gonzalez A; Mitsialis SA; Kourembanas S; Stahl A; Chen M; Xu H; Baranov P; Cai G; von Andrian UH; Sun Y
Mol Ther; 2024 May; 32(5):1425-1444. PubMed ID: 38504518
[TBL] [Abstract][Full Text] [Related]
35. miR-15b/16 protects primary human retinal microvascular endothelial cells against hyperglycemia-induced increases in tumor necrosis factor alpha and suppressor of cytokine signaling 3.
Ye EA; Steinle JJ
J Neuroinflammation; 2015 Mar; 12():44. PubMed ID: 25888955
[TBL] [Abstract][Full Text] [Related]
36. Expression of STAT3 and SOCS3 in pancreatic acinar cells.
Vona-Davis LC; Frankenberry KA; Waheed U; Peterson E; McFadden DW
J Surg Res; 2005 Jul; 127(1):14-20. PubMed ID: 15893771
[TBL] [Abstract][Full Text] [Related]
37. Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model.
Chakraborty G; Kumar S; Mishra R; Patil TV; Kundu GC
PLoS One; 2012; 7(3):e33633. PubMed ID: 22448259
[TBL] [Abstract][Full Text] [Related]
38. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling.
Wormald S; Zhang JG; Krebs DL; Mielke LA; Silver J; Alexander WS; Speed TP; Nicola NA; Hilton DJ
J Biol Chem; 2006 Apr; 281(16):11135-43. PubMed ID: 16473883
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease.
Gu Q; Kong Y; Yu ZB; Bai L; Xiao YB
Biochimie; 2011 May; 93(5):909-20. PubMed ID: 21354254
[TBL] [Abstract][Full Text] [Related]
40. Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophages.
Qasimi P; Ming-Lum A; Ghanipour A; Ong CJ; Cox ME; Ihle J; Cacalano N; Yoshimura A; Mui AL
J Biol Chem; 2006 Mar; 281(10):6316-24. PubMed ID: 16352613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
